Humira (Hu-MARE-ah, adalimumab), a new biologic therapy for rheumatoid arthritis
Abbott is now introducing Humira (Hu-MARE-ah, adalimumab), a new biologic therapy for rheumatoid arthritis.
It's a tumor necrosis factor (TNF) blocking agent...similar to Remicade (infliximab) and Enbrel (etanercept).
Humira is for moderate to severe RA that's not controlled by methotrexate or other disease-modifying antirheumatic drugs.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote